APA

Becerra C. R., Hanna N., McCollum A. D., Becharm N., Timmerman R. D., DiMaio M., Kesler K. A., Yu M., Yan T. & Choy H. (20140522). A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chicago

Becerra Carlos R, Hanna Nasser, McCollum Andrew David, Becharm Naftali, Timmerman Robert D, DiMaio Michael, Kesler Kenneth A, Yu Menggang, Yan Tong and Choy Hak. 20140522. A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Harvard

Becerra C. R., Hanna N., McCollum A. D., Becharm N., Timmerman R. D., DiMaio M., Kesler K. A., Yu M., Yan T. and Choy H. (20140522). A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MLA

Becerra Carlos R, Hanna Nasser, McCollum Andrew David, Becharm Naftali, Timmerman Robert D, DiMaio Michael, Kesler Kenneth A, Yu Menggang, Yan Tong and Choy Hak. A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 20140522.